Coreoside B

CAS No. 1580464-83-0

Coreoside B( —— )

Catalog No. M29477 CAS No. 1580464-83-0

Coreoside B is isolated from coreoside and showed weak antimicrobial activity against S. aureus and B. anthracis.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 302 Get Quote
10MG 447 Get Quote
25MG 714 Get Quote
50MG 1017 Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Coreoside B
  • Note
    Research use only, not for human use.
  • Brief Description
    Coreoside B is isolated from coreoside and showed weak antimicrobial activity against S. aureus and B. anthracis.
  • Description
    Coreoside B is isolated from coreoside and showed weak antimicrobial activity against S. aureus and B. anthracis.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    Antibacterial
  • Recptor
    Antibacterial
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1580464-83-0
  • Formula Weight
    528.55
  • Molecular Formula
    C25H36O12
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    OCCC(CC/C=C/C#CC#C/C=C/CO)O[C@@H]([C@@H]([C@H]1O)O[C@@H]([C@@H]([C@H]2O)O)OC[C@@H]2O)O[C@H](CO)[C@H]1O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Sulfamoxole

    Sulfamoxole is an antibacterial belonging to sulfonamide.

  • CB-618 sodium salt

    CB-618 (CB 238618) is a novel non-β-lactam β-lactamase inhibitor that potentiates meropenem MIC values against clinical Enterobacteriaceae isolates.

  • VXc-486

    VXc-486 (VXc486) is a novel inhibitor of gyrase B, potently inhibits multiple drug-sensitive isolates and drug-resistant isolates of Mycobacterium tuberculosis in vitro.